Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone

Journal of Experimental Medicine

Volumn 208, Issue 10, 2011, Pages 1941-1948

  Muppidi, Jagan R ^a,b   Arnon, Tal I ^a,b   Bronevetsky, Yelena ^b   Veerapen, Natacha ^c   Tanaka, Masato ^d   Besra, Gurdyal S ^c   Cyster, Jason G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANTIGEN; CANNABINOID 2 RECEPTOR; CD1D ANTIGEN; CXCL13 CHEMOKINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMORAL IMMUNITY; IMMUNITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SPLEEN;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ARACHIDONIC ACIDS; B-LYMPHOCYTES; GLYCERIDES; IMMUNITY, HUMORAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB2; RECEPTORS, LYSOSPHINGOLIPID; SPLEEN;

EID: 80555129348     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111083     Document Type: Article

References (33)

1. Attanavanich, K., and J.F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172:803-811.
2. Barral, P., J. Eckl-Dorna, N.E. Harwood, C. De Santo, M. Salio, P. Illarionov, G.S. Besra, V. Cerundolo, and F.D. Batista. 2008. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl. Acad. Sci. USA. 105:8345-8350
3. Brinkmann, V., A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin. 2010. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9:883-897
4. Bromley, S.K., S.Y. Thomas, and A.D. Luster. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6:895-901
5. Cinamon, G., M. Matloubian, M.J. Lesneski, Y. Xu, C. Low, T. Lu, R.L. Proia, and J.G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5:713-720
6. Cinamon, G., M.A. Zachariah, O.M. Lam, F.W. Foss Jr., and J.G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9:54-62
7. Galiègue, S., S. Mary, J. Marchand, D. Dussossoy, D. Carrière, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas. 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:54-61
8. Guinamard, R., M. Okigaki, J. Schlessinger, and J.V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:31-36.
9. Hardtke, S., L. Ohl, and R. Förster. 2005. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood. 106:1924-1931
10. Karlsson, M.C., R. Guinamard, S. Bolland, M. Sankala, R.M. Steinman, and J.V. Ravetch. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198:333-340
11. Kraus, M., M.B. Alimzhanov, N. Rajewsky, and K. Rajewsky. 2004. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell. 117:787-800
12. Leadbetter, E.A., M. Brigl, P. Illarionov, N. Cohen, M.C. Luteran, S. Pillai, G.S. Besra, and M.B. Brenner. 2008. NK T cells provide lipid antigenspecific cognate help for B cells. Proc. Natl. Acad. Sci. USA. 105:8339- 8344
13. Lo, C.G., Y. Xu, R.L. Proia, and J.G. Cyster. 2005. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201:291-301
14. Lu, T.T., and J.G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 297:409-412
15. Martin, F., and J.F. Kearney. 2001. B1 cells: similarities and differences with other B cell subsets. Curr. Opin. Immunol. 13:195-20
16. Martin, F., and J.F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323-335
17. Mebius, R.E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5:606-616
18. Miyake, Y., K. Asano, H. Kaise, M. Uemura, M. Nakayama, and M. Tanaka. 2007. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117:2268-2278
19. Munro, S., K.L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:61-65
20. Ohl, L., G. Bernhardt, O. Pabst, and R. Förster. 2003. Chemokines as organizers of primary and secondary lymphoid organs. Semin. Immunol. 15:249-25
21. Pereira, J.P., J. An, Y. Xu, Y. Huang, and J.G. Cyster. 2009a. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat. Immunol. 10:403-411
22. Pereira, J.P., L.M. Kelly, Y. Xu, and J.G. Cyster. 2009b. EBI2 mediates B cell segregation between the outer and centre follicle. Nature. 460:1122-1126.
23. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9:767-777
24. Regard, J.B., H. Kataoka, D.A. Cano, E. Camerer, L. Yin, Y.W. Zheng, T.S. Scanlan, M. Hebrok, and S.R. Coughlin. 2007. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J. Clin. Invest. 117:4034-4043.
25. Reif, K., E.H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Förster, and J.G. Cyster. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature. 416:94-99
26. Rinaldi-Carmona, M., F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, et al. 1998. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:644-650.
27. Sensken, S.C., C. Stäubert, P. Keul, B. Levkau, T. Schöneberg, and M.H. Gräler. 2008. Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate. Cell. Signal. 20:1125-1133
28. Sugiura, T., S. Oka, M. Gokoh, S. Kishimoto, and K. Waku. 2004. New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. J. Pharmacol. Sci. 96:367-375
29. Sugiura, T., S. Kishimoto, S. Oka, and M. Gokoh. 2006. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45:405-446
30. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:443-450
31. Tanikawa, T., K. Kurohane, and Y. Imai. 2007. Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. Microbiol. Immunol. 51:1013-1019.
32. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukoc. Biol. 45:97-104.
33. Ziring, D., B. Wei, P. Velazquez, M. Schrage, N.E. Buckley, and J. Braun. 2006. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics. 58:714-725